Associated Papers
Personal Genetic-Hypertension Odyssey From Phenotypes to Genotypes and Targets.
Luft FC
Hypertension (dallas, Tex. : 1979), 2024
Mutant Phosphodiesterase 3A Protects From Hypertension-Induced Cardiac Damage.
Ercu M et al.
Circulation, 2022
Identification and functional study of genetic polymorphisms in cyclic nucleotide phosphodiesterase 3A (PDE3A).
Kim YR et al.
Annals of Human Genetics, 2021
Whole-exome sequencing identifies a de novo PDE3A variant causing autosomal dominant hypertension with brachydactyly type E syndrome: a case report.
Li X et al.
Bmc Medical Genetics, 2020
The functional landscape of the human phosphoproteome.
Ochoa D et al.
Nature Biotechnology, 2020
31819260 (PubMed )
Supplement: EMS84831-supplement-Table_S5.xlsx › clinvar_data
Hypertension and Brachydactyly Syndrome Associated With Vertebral Artery Malformation Caused by a PDE3A Missense Mutation.
Fan P et al.
American Journal of Hypertension, 2020
Systematic analysis of the intersection of disease mutations with protein modifications.
Simpson CM et al.
Bmc Medical Genomics, 2019
31345222 (PubMed )
Supplement: 12920_2019_543_MOESM5_ESM.xlsx › S4
PDE3A gene screening improves diagnostics for patients with Bilginturan syndrome (hypertension and brachydactyly syndrome).
Renkema KY et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension, 2018
Clinical effects of phosphodiesterase 3A mutations in inherited hypertension with brachydactyly.
Toka O et al.
Hypertension (dallas, Tex. : 1979), 2015
PDE3A mutations cause autosomal dominant hypertension with brachydactyly.
Maass PG et al.
Nature Genetics, 2015
Select a paper to view details